Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer
PI3K抑制剂Alpelisib联合白蛋白紫杉醇治疗HER2阴性转移性乳腺癌的I/II期临床及生物标志物研究结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-4879
Sharma, Priyanka; Abramson, Vandana G; O'Dea, Anne; Nye, Lauren; Mayer, Ingrid; Pathak, Harsh B; Hoffmann, Marc; Stecklein, Shane R; Elia, Manana; Lewis, Sharon; Scott, Jecinta; De Jong, Jilliann A; Wang, Yen Y; Yoder, Rachel; Schwensen, Kelsey; Finke, Karissa; Heldstab, Jaimie; LaFaver, Stephanie; Williamson, Stephen K; Phadnis, Milind A; Reed, Gregory A; Kimler, Bruce F; Khan, Qamar J; Godwin, Andrew K